Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
August 03, 2023
No healthcare system has an unlimited budget, and policy makers everywhere must balance demand for new health services with finite resources. Priority setting systems, often in the form of health technology assessment (HTA), can help evaluate whether health services provide good value for the money...
Blog Post
May 22, 2023
The climate mitigation work is an urgent development mission. The world has probably already lost the battle to limit warming to 1.5 degrees Celsius by 2050. Even now, millions of people in developing countries are suffering and dying due to natural disasters and sea level rise made worse by past an...
Blog Post
May 02, 2019
On Monday, 600 delegates from development partners, NGOs, think tanks, and civil society organizations gathered at the United Nations in New York for an interactive multi-stakeholder hearing on Universal Health Coverage (UHC). Stakeholders discussed pertinent issues and inputs needed for a...
CGD NOTES
May 01, 2019
As low- and middle-income countries shift away from donor support, their challenge will be finding a way to aggregate demand in order to achieve the benefits that the pooled purchasing arrangements of vertical health programs now provide. As a first step in tackling this challenge, much can be learn...
WORKING PAPERS
April 03, 2019
This paper focuses on the role that price transparency may play in the efficient and effective procurement of medicines by middle- and low-income countries. Will making prices publicly available make procurement more efficient and cost-effective medicines more accessible? We conclude that transparen...
Blog Post
March 26, 2019
At the end of 2018, the world had seven development impact bonds (DIBs) and more in the pipeline. Yet questions remain about the potential of DIBs—still a new financing instrument—compared to other pay-for-performance arrangements. With a dearth of standard and transparent evaluation met...
Blog Post
November 13, 2018
Back in February, the US Council of Economic Advisers issued a white paper on drug pricing implying that other rich countries should stop “free riding” off American innovation by negotiating drug prices to unfairly low levels after the US fronts the research and development cos...
Blog Post
May 02, 2018
There is much to cheer about in last week’s announcement by the World Bank’s shareholders to increase its paid-in capital by $13 billion. It is a healthy signal that multilateralism is alive and well, at least in the development space. And on a practical level it is sufficient to en...